May 10, 2018 / 12:12 PM / 6 months ago

BRIEF-Celldex Therapeutics Reports Q1 Loss Per Share $0.84

May 10 (Reuters) - Celldex Therapeutics Inc:

* CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 RESULTS

* Q1 REVENUE $4.1 MILLION VERSUS $1.5 MILLION

* Q1 REVENUE VIEW $2.3 MILLION -- THOMSON REUTERS I/B/E/S

* Q1 EARNINGS PER SHARE VIEW $-0.20 -- THOMSON REUTERS I/B/E/S

* CELLDEX - SEES CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES AT MAR 31, PROCEEDS FROM SALES OF STOCK SUFFICIENT TO FUND OPERATIONS THROUGH 2020

* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF MARCH 31, 2018 WERE $123.2 MILLION VERSUS $139.4 MILLION AS OF DEC 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below